BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38619282)

  • 1. THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling.
    Deborah EA; Nabekura T; Shibuya K; Shibuya A
    J Immunol; 2024 Jun; 212(11):1819-1828. PubMed ID: 38619282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
    Pievani A; Borleri G; Pende D; Moretta L; Rambaldi A; Golay J; Introna M
    Blood; 2011 Sep; 118(12):3301-10. PubMed ID: 21821703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
    Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
    Front Immunol; 2020; 11():40. PubMed ID: 32082316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer.
    Shi L; Li K; Guo Y; Banerjee A; Wang Q; Lorenz UM; Parlak M; Sullivan LC; Onyema OO; Arefanian S; Stelow EB; Brautigan DL; Bullock TNJ; Brown MG; Krupnick AS
    Proc Natl Acad Sci U S A; 2018 Nov; 115(46):11808-11813. PubMed ID: 30381460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors.
    Veneziani I; Infante P; Ferretti E; Melaiu O; Battistelli C; Lucarini V; Compagnone M; Nicoletti C; Castellano A; Petrini S; Ognibene M; Pezzolo A; Di Marcotullio L; Bei R; Moretta L; Pistoia V; Fruci D; Barnaba V; Locatelli F; Cifaldi L
    Cancer Immunol Res; 2021 Feb; 9(2):170-183. PubMed ID: 33303573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
    Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC
    Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Themis2 regulates natural killer cell memory function and formation.
    Nabekura T; Deborah EA; Tahara S; Arai Y; Love PE; Kako K; Fukamizu A; Muratani M; Shibuya A
    Nat Commun; 2023 Nov; 14(1):7200. PubMed ID: 37938555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development.
    Jelenčić V; Šestan M; Kavazović I; Lenartić M; Marinović S; Holmes TD; Prchal-Murphy M; Lisnić B; Sexl V; Bryceson YT; Wensveen FM; Polić B
    Nat Immunol; 2018 Oct; 19(10):1083-1092. PubMed ID: 30224819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.
    Konjević G; Mirjacić Martinović K; Vuletić A; Jović V; Jurisić V; Babović N; Spuzić I
    Clin Exp Metastasis; 2007; 24(1):1-11. PubMed ID: 17295095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKG2D and its ligands.
    Obeidy P; Sharland AF
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2364-7. PubMed ID: 19631280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMBOX1 negatively regulates NK cell functions by suppressing the NKG2D/DAP10 signaling pathway.
    Wu L; Zhang C; Zhang J
    Cell Mol Immunol; 2011 Sep; 8(5):433-40. PubMed ID: 21706044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells.
    Lo Monaco E; Tremante E; Cerboni C; Melucci E; Sibilio L; Zingoni A; Nicotra MR; Natali PG; Giacomini P
    Neoplasia; 2011 Sep; 13(9):822-30. PubMed ID: 21969815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation.
    Malarkannan S; Regunathan J; Chu H; Kutlesa S; Chen Y; Zeng H; Wen R; Wang D
    J Immunol; 2007 Sep; 179(6):3752-62. PubMed ID: 17785812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
    Lowin-Kropf B; Kunz B; Schneider P; Held W
    Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
    Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
    Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
    Zhang C; Röder J; Scherer A; Bodden M; Pfeifer Serrahima J; Bhatti A; Waldmann A; Müller N; Oberoi P; Wels WS
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells.
    Coudert JD; Zimmer J; Tomasello E; Cebecauer M; Colonna M; Vivier E; Held W
    Blood; 2005 Sep; 106(5):1711-7. PubMed ID: 15886320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.